Markets are Closed
PFE
Pfizer Inc.
Open
38.30
Previous Open
—
High
38.62
Previous High
—
Low
38.16
Previous Low
—
Close
38.45
Previous Close
—
Volume
44,134,742
Previous Volume
—
Company Profile
Description
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
Exchange
New York Stock Exchange
List Date
January 02, 1990
CEO
Ian C. Read
Employees
90,200
Related Stocks
Financials
Revenue
51.75B
Earnings
17.65B
59B
46B
33B
20B
7B
2015
2016
2017
2018
Splits
| July 01, 1999 | 0.33% |
Dividends
| September 01, 2020 | $0.38 |
| June 05, 2020 | $0.38 |
| March 06, 2020 | $0.38 |
| December 02, 2019 | $0.36 |
| September 03, 2019 | $0.36 |
| June 07, 2019 | $0.36 |
| March 01, 2019 | $0.36 |
| December 03, 2018 | $0.34 |
| September 04, 2018 | $0.34 |
| June 01, 2018 | $0.34 |
| March 01, 2018 | $0.34 |
| December 01, 2017 | $0.32 |
| September 01, 2017 | $0.32 |
| June 01, 2017 | $0.32 |
| March 01, 2017 | $0.32 |
| December 01, 2016 | $0.30 |
| September 01, 2016 | $0.30 |
| June 01, 2016 | $0.30 |
| March 02, 2016 | $0.30 |
| December 01, 2015 | $0.28 |
| September 02, 2015 | $0.28 |
| June 02, 2015 | $0.28 |
| March 03, 2015 | $0.28 |
| December 02, 2014 | $0.26 |
| September 03, 2014 | $0.26 |
| June 03, 2014 | $0.26 |
| March 04, 2014 | $0.26 |
| December 03, 2013 | $0.24 |
| September 04, 2013 | $0.24 |
Related News
Pfizer Completes $1.25 Billion Sustainability Bond for Social and Environmental Impact
Mar 27, 2020 @ 14:20
Pfizer Inc. (NYSE: PFE) today announced the completion of a $1.25 billion ten-year "sustainability" bond paying interest semi-annually of 2.625 percent and maturing April 1, 2030. This is Pfizer’s first-ever sustainability bond and a first for a biopharmaceutical company....
finance yahoo
Pfizer Stock Falls 3%
Mar 27, 2020 @ 09:31
Investing.com - Pfizer (NYSE:PFE) Stock fell by 3.17% to trade at $30.68 by 09:30 (13:30 GMT) on Friday on the NYSE exchange....
finance yahooPfizer Stock Rises 5%
Mar 26, 2020 @ 13:50
Investing.com - Pfizer (NYSE:PFE) Stock rose by 5.31% to trade at $31.36 by 13:48 (17:48 GMT) on Thursday on the NYSE exchange....
finance yahoo
Mylan delays merger with Upjohn due to COVID-19 pandemic
Mar 26, 2020 @ 11:22
The Mylan NV-Upjohn merger is being pushed back into the second half of 2020 due to the COVID-19 global pandemic. Mylan NV (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE), which owns Upjohn, announced Thursday that COVID-19 is moving the expected merger date from the first half of the year and Mylan's meeting of shareholders to approve it is being moved from April 27 to June 30. Mylan and Upjohn announced last July that they would be merging to create a global pharmaceutical giant, in both generic and brand name drugs....
finance yahoo
Drugmakers Mylan, Pfizer delay merger due to coronavirus outbreak
Mar 26, 2020 @ 11:01
Due to restrictions on large gatherings, the general meeting of shareholders to approve certain matters for the deal to go through has been postponed to June 30, Mylan said. There were no other changes to previously announced terms or plans pertaining to the deal, previously expected to close in mid...
finance yahoo
Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 26, 2020 @ 10:45
Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that due to the unprecedented circumstances surrounding the COVID-19 pandemic, including associated delays in the regulatory review process, the proposed transaction involving Mylan and Upjohn, a division of Pfizer, is now anticipated...
finance yahoo
Pfizer (PFE) Gains But Lags Market: What You Should Know
Mar 25, 2020 @ 21:45
Pfizer (PFE) closed at $29.75 in the latest trading session, marking a +0.17% move from the prior day....
finance yahoo
Pfizer pauses new studies due to coronavirus
Mar 25, 2020 @ 17:07
March 25 (Reuters) - Pfizer Inc said on Wednesday it was pausing patient recruitment in new and ongoing global studies for three weeks due to the coronavirus outbreak....
finance yahoo
Pfizer's Eczema Drug Eucrisa Gets FDA Approval for Infants
Mar 25, 2020 @ 14:08
Pfizer (PFE) gets FDA approval for label expansion of Eucrisa to include children aged three months to two years with mild-to-moderate atopic dermatitis or eczema....
finance yahooPfizer's Cardiomyopathy Drug Vyndaqel Gets Approval in Europe
Feb 19, 2020 @ 14:23
Pfizer's (PFE) Vyndaqel gets approval in Europe and becomes the first therapy approved to treat ATTR-CM in the continent....
finance yahoo